Literature DB >> 24939067

A novel application of CT angiography to detect extracoronary vascular abnormalities in patients with spontaneous coronary artery dissection.

Jackson J Liang1, Megha Prasad1, Marysia S Tweet2, Sharonne N Hayes2, Rajiv Gulati2, Jerome F Breen3, Shuai Leng3, Terri J Vrtiska4.   

Abstract

BACKGROUND: Spontaneous coronary artery dissection (SCAD) is associated with extracoronary vascular abnormalities, which depending on type and location may warrant treatment or provide additional diagnostic or prognostic information about this uncommon entity. Fibromuscular dysplasia (FMD), aneurysms, and dissections have been detected in multiple vascular territories by magnetic resonance angiography, CT angiography (CTA), and catheter angiography. The optimal modality to detect extracoronary vascular abnormalities is unknown. We highlight the technique and feasibility of a novel CTA protocol to detect extracoronary vascular abnormalities in these patients, incorporating patient safety and convenience.
METHODS: The complete CTA protocol consisting of a single CTA of the neck, chest, abdomen, and pelvis was performed on 39 SCAD outpatients. All examinations were performed with 200 mL of low-osmolar contrast agent and used radiation dose modulation techniques. Average volume CT dose index was 9 mGy for the chest, abdomen, and pelvis portions and 21 mGy for the neck portion. Studies were independently reviewed by 2 senior vascular radiologists.
RESULTS: Two patients had nondiagnostic CTA neck evaluation because of technical acquisition errors. Extracoronary vascular abnormalities were detected in 27 of 39 patients (69%). Catheter angiography detected brachial artery FMD in 1 patient, a vascular bed not included in the SCAD CTA protocol. Extracoronary vascular abnormalities were common, including FMD, aneurysms, dissection, and aortic tortuosity, and were seen in the iliac (36%), carotid and/or vertebral (31%), splanchnic (10%), and renal (26%) arteries and in the thoracic and/or abdominal aorta (10%).
CONCLUSIONS: The frequency of extracoronary vascular abnormalities and extent of territories identified the CTA protocol in our cohort are high. A tailored CTA may be the optimal imaging technique for detecting extracoronary vascular abnormalities in patients with suspected underlying vasculopathy. Although the clinical significance of extracoronary vascular abnormalities remains unclear, detection of these abnormalities has identified patients in whom cerebral imaging and serial monitoring have been recommended.
Copyright © 2014 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography angiography; Fibromuscular dysplasia; Myocardial infarction; SCAD; Screening; Spontaneous coronary artery dissection

Mesh:

Year:  2014        PMID: 24939067     DOI: 10.1016/j.jcct.2014.02.001

Source DB:  PubMed          Journal:  J Cardiovasc Comput Tomogr        ISSN: 1876-861X


  14 in total

Review 1.  Spontaneous coronary artery dissection: novel insights on diagnosis and management.

Authors:  Fernando Alfonso; Teresa Bastante; Javier Cuesta; Daniel Rodríguez; Amparo Benedicto; Fernando Rivero
Journal:  Cardiovasc Diagn Ther       Date:  2015-04

Review 2.  Spontaneous Coronary Artery Dissection.

Authors:  Marysia S Tweet; Rajiv Gulati; Sharonne N Hayes
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

Review 3.  Role of Invasive and Non-invasive Imaging Tools in the Diagnosis and Optimal Treatment of Patients with Spontaneous Coronary Artery Dissection.

Authors:  Enrico Cerrato; Federico Giacobbe; Cristina Rolfo; Giorgio Quadri; Francesco Tomassini; Fabio Ferrari; Fabio Mariani; Matteo Anselmino; Matteo Bianco; Davide Belliggiano; Luca Lo Savio; Alfonso Franzé; Umberto Barbero; Italo Porto; Hernán Mejía-Rentería; Fernando Macaya; Pablo Salinas; Nieves Gonzalo; Javier Escaned; Laura Montagna; Ferdinando Varbella
Journal:  Curr Cardiol Rep       Date:  2019-09-03       Impact factor: 2.931

4.  European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection.

Authors:  David Adlam; Fernando Alfonso; Angela Maas; Christiaan Vrints
Journal:  Eur Heart J       Date:  2018-09-21       Impact factor: 29.983

Review 5.  Spontaneous coronary artery dissection in women: What is known and what is yet to be understood.

Authors:  Marysia S Tweet; Susan N Kok; Sharonne N Hayes
Journal:  Clin Cardiol       Date:  2018-03-01       Impact factor: 2.882

Review 6.  Non-atherosclerotic causes of acute coronary syndromes.

Authors:  Thomas M Waterbury; Giuseppe Tarantini; Birgit Vogel; Roxana Mehran; Bernard J Gersh; Rajiv Gulati
Journal:  Nat Rev Cardiol       Date:  2019-10-03       Impact factor: 32.419

Review 7.  Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.

Authors:  Sharonne N Hayes; Esther S H Kim; Jacqueline Saw; David Adlam; Cynthia Arslanian-Engoren; Katherine E Economy; Santhi K Ganesh; Rajiv Gulati; Mark E Lindsay; Jennifer H Mieres; Sahar Naderi; Svati Shah; David E Thaler; Marysia S Tweet; Malissa J Wood
Journal:  Circulation       Date:  2018-02-22       Impact factor: 29.690

Review 8.  Coronary computed tomography angiography of spontaneous coronary artery dissection: a case report and review of the literature.

Authors:  Stephanie C Torres-Ayala; Jose Maldonado; J Scott Bolton; Sanjeev Bhalla
Journal:  Am J Case Rep       Date:  2015-03-04

Review 9.  Recent developments in the understanding and management of fibromuscular dysplasia.

Authors:  Sarah C O'Connor; Heather L Gornik
Journal:  J Am Heart Assoc       Date:  2014-12       Impact factor: 5.501

10.  Prevalence and Clinical Factors of Migraine in Patients With Spontaneous Coronary Artery Dissection.

Authors:  Susan N Kok; Sharonne N Hayes; F Michael Cutrer; Claire E Raphael; Rajiv Gulati; Patricia J M Best; Marysia S Tweet
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.